Delivery Order SPE2DB24D2106-SPE2DB25FAUXF

Award Date 4/1/25
Potential Completion Date 4/2/25
Potential Value $33K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the procurement of ORENCIA CLICKJECT 125 MG/ML medication. The contract has a ceiling value of $52,135.44 and a completion date of September 10, 2024. This award is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which has a potential value of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $35,215.12, provides for the delivery of Orencia Clickject 125 mg/mL, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This federal contract award, valued at $28,118.62, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of ORENCIA CLICKJECT 125 MG/MLML, a pharmaceutical product, with an ultimate completion date of March 10, 2025. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of ORENCIA CLICKJECT 125 MG/MLML pharmaceuticals, with a ceiling value of $24,302.58 and a period of performance through August 21, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. DMS Pharmaceutical Group is a key supplier in the federal...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $22,734.34, is for the delivery of Orencia ClickJect 125 mg/mL, a specialized biologic medication, to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $39,190.87 firm fixed-price delivery order is for the supply of ORENCIA CLICKJECT 125 MG/ML pharmaceutical products. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a comprehensive range of...
This federal contract award from the Defense Logistics Agency (DLA) was granted to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $28,761.07 firm fixed-price delivery order is for the supply of ORENCIA CLICKJECT 125 MG/MLML, a specialized pharmaceutical product. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $34,730.74, is a firm fixed-price delivery order for the supply of Orencia Clickject 125 mg/mL, a specialized pharmaceutical product. The contract has no set-aside designation and is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
This federal contract award, with ID SPE2DB24D2106|SPE2DB25FAUVF, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $12,210.86 firm fixed-price delivery order is for ORENCIA CLICKJECT 125 MG/MLML, a specialized pharmaceutical product. The contract has an ultimate completion date of March 25, 2025. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $23,494.60 firm fixed-price delivery order is for the procurement of 4565829433 ORENCIA CLICKJECT 125 MG/ML. This award is part of a larger single-award indefinite delivery contract (IDC) between DMS Pharmaceutical Group and DLA under the SPE2DB program, valued at up to $499,999,999 and running...
  • SPE2DB24D2106
    Indefinite Delivery Contract
  • SPE2DB24D2106-SPE2DB25FAUXF
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $33,196.77, is for the provision of ORENCIA CLICKJECT 125 MG/MLML, a specialized pharmaceutical product. The contract does not have a set-aside designation.

DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide. The company holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical items.

Generated 7/1/25, 10:49 AM